Search results for "Patient acceptance"

showing 8 items of 88 documents

Social functioning as a significant factor in women's help-seeking behaviour during the climacteric period.

1993

In order to identify the psychosocial factors that lead to the demand for medical care related to the menopause, we carried out a case/control study. A case was defined as a woman who sought gynaecological care due to "menopausal complaints" (n = 85) and a control referred to a woman drawn at random from the general population. The cases showed greater psychiatric morbidity and social dissatisfaction, a lower level of diffused social support and a higher frequency of severe life events and the controls showed greater social maladjustment in objective conditions. The multivariate analysis (logistic regression) carried out after adjusting all the relevant variables, indicated that the demand …

medicine.medical_specialtyHealth (social science)Multivariate analysisSocial PsychologyEpidemiologyPopulationLogistic regressionLife Change EventsSocial supportRisk FactorsEpidemiologymedicineHumansWomenPsychiatryeducationeducation.field_of_studySocializationSocial SupportMiddle AgedPatient Acceptance of Health Caremedicine.diseaseHelp-seekingMenopausePsychiatry and Mental healthMental HealthCase-Control StudiesWomen's HealthFemaleMenopausePsychologyPsychosocialSocial AdjustmentSocial psychiatry and psychiatric epidemiology
researchProduct

Correlates of hormone replacement therapy use in Italian women, 1992-1996

1999

we analyzed the determinants of hormonal replacement therapy (HRT) use in Italy for the period 1992-1996, using data from a framework of case-control studies of colon and rectal neoplasm.a total of 1574 women aged 45-74 years were considered. This group comprised women with acute, non neoplastic, non-hormone-related diseases admitted to a network of hospitals in six areas of Italy.a total of 146 women (8.5%) reported ever HRT use. The multivariate odds ratio (OR) of ever use was 1.6 (95% CI 1.0-2.6) for women with 12 years of education or more, compared with those with7 years. The frequency of use of HRT tended to decrease with increasing parity: the OR was 0.6 for women with four or more c…

medicine.medical_specialtyNon neoplasticmenopauseGeneral Biochemistry Genetics and Molecular BiologyInternal medicineRectal NeoplasmmedicineHumansSocioeconomic statusAgedClimactericGynecologybusiness.industryEstrogen Replacement TherapyHormonal replacement therapyObstetrics and GynecologyOdds ratiocase control studyMiddle AgedPatient Acceptance of Health CareHormone replacement therapyItalyTransgender hormone therapyHormone replacement therapy; case control study; menopauseFemalebusinessHuman
researchProduct

Efficacy and acceptance of the sacral neuromodulation in the treatment of female lower urinary tract dysfunctions.

2017

medicine.medical_specialtySacrum030232 urology & nephrologyUrologyMEDLINEElectric Stimulation Therapylower urinary tract dysfunctionsacral neuromodulationFemale lower urinary tract03 medical and health sciences0302 clinical medicineMedicineHumansElectric stimulation therapyProspective StudiesProspective cohort study030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryUrinary retentionUrinary Bladder OveractiveObstetrics and GynecologyMiddle AgedPatient Acceptance of Health CareUrinary RetentionSacrummedicine.anatomical_structureTreatment OutcomeSacral nerve stimulationFemalemedicine.symptombusinessMinerva ginecologica
researchProduct

Screening for colorectal cancer with immunochemical faecal occult blood tests.

2012

Population-based studies have shown that guaiac faecal occult blood testing followed by colonoscopy in case of positivity can reduce colorectal cancer mortality. However these tests have been criticised for their fairly low sensitivity. For this reason attention has been given to alternative tests. The aim of this paper is to review the evidence for screening for colorectal cancer using qualitative immunochemical faecal occult blood tests. For the complete range of tested cut-off values, immunochemical faecal occult blood tests lead to higher diagnostic yield, improved sensitivity and greater participation. The optimal number of samples and the optimal cut-off value has to suit local resour…

medicine.medical_specialtyScreening testColorectal cancerCost-Benefit AnalysisPopulationColonoscopyGastroenterologySensitivity and SpecificityChromatography AffinityJapanInternal medicinemedicineHumansMass ScreeningSampling (medicine)educationMass screeningEarly Detection of Cancereducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyFaecal occult bloodPatient Acceptance of Health Caremedicine.diseaseEuropeOccult BloodNorth AmericaIndicators and ReagentsFaecal occult blood testbusinessColorectal NeoplasmsGuaiacDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.

2015

Objective:Across Italy up to 7.3% of the population is infected with hepatitis C virus (HCV), with long-term complications resulting in high medical costs and significant morbidity and mortality. Current treatment options have limitations due to side effects, interferon intolerability and ineligibility, long treatment durations and low sustained virological response (SVR) rates, especially for the most severe patients). Sofosbuvir is the first nucleotide polymerase inhibitor with pan-genotypic activity. Sofosbuvir, administered with ribavirin (RBV) and with or without pegylated interferon (PEG-INF), resulted in >90% SVR across treatment-naïve (TN) genotype (GT) 1-6 patients. It is also t…

medicine.medical_specialtySofosbuvirGenotypeCost effectivenessHepatitis C virusCost-Benefit AnalysisAlpha interferonmedicine.disease_causeGastroenterologyPolyethylene GlycolAntiviral AgentsSeverity of Illness IndexTelaprevirTelaprevirPolyethylene Glycolschemistry.chemical_compoundPegylated interferonBoceprevirInternal medicineQuality-Adjusted Life YearRibavirinmedicineCost-effectiveness analysiHumansCost-Benefit AnalysiAntiviral AgentBoceprevirbusiness.industryHealth PolicyRibavirinInterferon-alphaMarkov ChainHepatitis C ChronicPatient Acceptance of Health CareVirologyChronic hepatitis C infectionMarkov ChainschemistryItalyDrug Therapy CombinationQuality-Adjusted Life YearsSofosbuvirbusinessmedicine.drugHumanJournal of medical economics
researchProduct

Is global elimination of HCV realistic?

2017

The elimination of hepatitis C virus (HCV) has been made possible through the availability of new antiviral drugs which may now be administered to all patients with HCV infection, even those with decompensated cirrhosis. The goal of the World Health Organization (WHO) is to reduce the incidence of chronic hepatitis infection from the current 6-10 million to 0.9 million cases of chronic infections by 2030, and annual deaths from 1.4 million to fewer than 0.5 million. Achieving these targets will require full implementation of epidemiological knowledge of HCV infection, screening and testing practices and strategies to link HCV patients to care. This review will focus on the current state of …

medicine.medical_specialtySustained Virologic ResponseHepatitis C virusCost-Benefit Analysismedicine.disease_causeGlobal HealthWorld Health OrganizationAntiviral AgentsWorld health03 medical and health sciences0302 clinical medicineChronic hepatitisInternal medicineEpidemiologymedicineHumansMass Screening030212 general & internal medicineDisease EradicationIntensive care medicineSubstance Abuse Intravenouslinkage to caredirect antiviral agentHepatologybusiness.industryscreeningIncidence (epidemiology)Hcv clearancevirus diseasesHepatologyPatient Acceptance of Health CareHepatitis Cdigestive system diseases030211 gastroenterology & hepatologybusinessPatient awarenessLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Use of telemedicine in inflammatory bowel disease: a real monitoring option?

2016

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic and relapsing disorder characterized by inflammation of the gastrointestinal tract. The natural progression includes periods of flares and remission, requiring continuous and personalized follow-up to achieve long remission and minimize short and long term damage. In fact, IBD patients show significantly higher rates of utilization of healthcare resources than patients with other conditions [1]. It is important to emphasize that 30-45% of adults are nonadherents [2], making these patients five times more likely to suffer relapses and consequently increasing health care costs [3]. …

medicine.medical_specialtyTelemedicineHealth Knowledge Attitudes PracticeDiseaseInflammatory bowel diseaseGastroenterology03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Internal medicineHealth caremedicineHumansIntensive care medicineCrohn's diseaseHepatologybusiness.industryWork disabilityAttitude to ComputersDelivery of Health Care IntegratedRemote ConsultationGastroenterologyPatient Acceptance of Health Caremedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesTelemedicineTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessExpert review of gastroenterologyhepatology
researchProduct

Colorectal Polyps

2008

Publisher Summary Colorectal cancer (CRC) remains the second leading cause of cancer death for both women and men with more than 130,000 newly diagnosed cases and 50,000 deaths each year in the United States alone. Most colon cancers develop from nonmalignant colonic adenomas or polyps over a comparatively long time period ranging between 24 and 60 months. Reflecting this adenomatous pathogenesis of most colorectal cancers, polyp screening with subsequent polypectomy is used to constitute an effective approach for decreasing the incidence of this malignant tumor. Thus, colorectal screening for polyps may be considered one of the most promising preventive measures in medicine. Most available…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryColorectal cancerIncidence (epidemiology)medicine.medical_treatmentColonoscopyMagnetic resonance imagingmedicine.diseaseGastroenterologydigestive system diseasesPatient acceptancePolypectomyOccult fecal bloodInternal medicinemedicinebusinessBarium enema
researchProduct